Bausch Health Companies (BHC) Inventory Average (2010 - 2026)
Bausch Health Companies (BHC) posted Inventory Average of $1.6 billion for Q2 2026, down 0.84% sequentially from $1.6 billion in Q1 2026, and down 1.99% YoY from $1.6 billion in Q2 2025.
Bausch Health Companies (BHC) Inventory Average (2010 - 2026) Analysis & Trends
Bausch Health Companies has reported Inventory Average for 17 years, with the latest figure at $1.6 billion in Q2 2026.
- Quarterly Inventory Average fell 1.99% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (down 1.99% YoY) and the FY2025 annual result came in at $1.6 billion, up 2.71% from the prior year.
- Inventory Average eased to $1.6 billion in Q2 2026 per BHC's latest filing, from $1.6 billion in the prior quarter.
- Over five years, Inventory Average peaked at $1.6 billion in Q2 2025 and troughed at $1.0 billion in Q1 2022.
- A 5-year average of $1.4 billion and a median of $1.6 billion in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2024: Inventory Average declined 6.08% in 2022, then surged 37.54% in 2024.
- Over 5 years, Inventory Average stood at $1.1 billion in 2022, then jumped by 31.22% to $1.4 billion in 2023, then rose by 15.41% to $1.6 billion in 2024, then retreated by 0.71% to $1.6 billion in 2025, then dropped by 0.74% to $1.6 billion in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $1.6 billion, $1.6 billion, and $1.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 824.00 Mn |
| 10 | Bausch Health Companies | 2.57 Bn | 734.50 Mn | 2.10 Bn | 1.60 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Bn |
| Mar 31, 2026 | 1.62 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.63 Bn |
| Jun 30, 2025 | 1.63 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 1.63 Bn |
| Sep 30, 2024 | 1.63 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.59 Bn |
| Dec 31, 2023 | 1.41 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.16 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.06 Bn |
| Jun 30, 2022 | 1.06 Bn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 1.07 Bn |